Search

Your search keyword '"Raghunathan, Nirupa J."' showing total 15 results
Start Over Author "Raghunathan, Nirupa J."
15 results on '"Raghunathan, Nirupa J."'

7. Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors

Author

Salz, Talya, primary, Zabor, Emily C., additional, Brown, Peter De Nully, additional, Dalton, Susanne Oksbjerg, additional, Raghunathan, Nirupa J., additional, Matasar, Matthew J., additional, Steingart, Richard, additional, Hjalgrim, Henrik, additional, Specht, Lena, additional, Vickers, Andrew J., additional, Oeffinger, Kevin C., additional, and Johansen, Christoffer, additional

Published
2022
Full Text
View/download PDF

8. Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors

Author

Salz, Talya, Zabor, Emily C., De Nully Brown, Peter, Dalton, Susanne Oksbjerg, Raghunathan, Nirupa J., Matasar, Matthew J., Steingart, Richard, Hjalgrim, Henrik, Specht, Lena, Vickers, Andrew J., Oeffinger, Kevin C., and Johansen, Christoffer

Abstract

Mediastinal radiation is associated with increased risk of myocardial infarction (MI) among non-Hodgkin lymphoma (NHL) survivors. To evaluate how preexisting cardiovascular risk factors (CVRFs) modify the association of mediastinal radiation and MI among a national population of NHL survivors with a range of CVRFs. Using Danish registries, we identified adults diagnosed with lymphoma 2000–2010. We assessed MI from one year after diagnosis through 2016. We ascertained CVRFs (hypertension, dyslipidemia, and diabetes), vascular disease, and intrinsic heart disease prevalent at lymphoma diagnosis. We used multivariable Cox regression to test the interaction between preexisting CVRFs and receipt of mediastinal radiation on subsequent MI. Among 3151 NHL survivors (median age 63, median follow-up 6.5 years), 96 were diagnosed with MI. Before lymphoma, 32% of survivors had ≥1 CVRF. 8.5% of survivors received mediastinal radiation. In multivariable analysis, we found that mediastinal radiation (HR = 1.96; 95% CI = 1.09–3.52), and presence of ≥1 CVRF (HR = 2.71; 95% CI = 1.77–4.15) were associated with an increased risk of MI. Although there was no interaction on the relative scale (p = 0.14), we saw a clinically relevant absolute increase in risk for patients with CVRF from 10-year of MI of 10.5% without radiation to 29.5% for those undergoing radiation. Patients with CVRFs have an importantly higher risk of subsequent MI if they have mediastinal radiation. Routine evaluation of CVRFs and optimal treatment of preexisting cardiovascular disease should continue after receiving cancer therapy. In patients with CVRFs, mediastinal radiation should only be given if oncologic benefit clearly outweighs cardiovascular harm.

Published
2022
Full Text
View/download PDF

11. Incorporating Multiple Perspectives Into the Development of an Electronic Survivorship Platform for Head and Neck Cancer

Author

Salz, Talya, primary, Schnall, Rebecca B., additional, McCabe, Mary S., additional, Oeffinger, Kevin C., additional, Corcoran, Stacie, additional, Vickers, Andrew J., additional, Salner, Andrew L., additional, Dornelas, Ellen, additional, Raghunathan, Nirupa J., additional, Fortier, Elizabeth, additional, McKiernan, Janet, additional, Finitsis, David J., additional, Chimonas, Susan, additional, and Baxi, Shrujal, additional

Published
2018
Full Text
View/download PDF

13. Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors

Author

Salz, Talya, primary, Zabor, Emily C., additional, de Nully Brown, Peter, additional, Dalton, Susanne Oksberg, additional, Raghunathan, Nirupa J., additional, Matasar, Matthew J., additional, Steingart, Richard, additional, Vickers, Andrew J., additional, Svenssen Munksgaard, Peter, additional, Oeffinger, Kevin C., additional, and Johansen, Christoffer, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results